NCT03138850

Brief Summary

The purpose of this study is to compare the effect of mandibular advancement bite block and high flow nasal cannula to standard bite block for oxygenation, capnographic measurement, prevention of hypoxemia, intervention events and adverse effects during endoscopic examinations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 3, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

May 3, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2017

Completed
Last Updated

July 11, 2017

Status Verified

May 1, 2017

Enrollment Period

2 months

First QC Date

April 18, 2017

Last Update Submit

July 6, 2017

Conditions

Keywords

intravenous sedationesophagogastroduodenalscopyupper airwaymandibular advancement devicehigh flow nasal cannula

Outcome Measures

Primary Outcomes (1)

  • Area under the curve of 95% oxygen desaturation (AUCdesat)

    AUCdesat is defined as the integrated area under oxygen saturation (SPO2) for a selected cut point per 30 seconds, which better reflects the duration and severity of hypoxemia than the lowest saturation

    From time of first sedative medication given until the time of discharge from recovery room, assessed up to 1 hour

Secondary Outcomes (4)

  • Number of rescue interventions

    From time of first sedative medication given until the time of discharge from recovery room, assessed up to 1 hour

  • Number of apnea episodes

    From time of first sedative medication given until the time of discharge from recovery room, assessed up to 1 hour

  • Number of partial airway obstruction episodes

    From time of first sedative medication given until the time of discharge from recovery room, assessed up to 1 hour

  • Number of total airway obstruction episodes

    From time of first sedative medication given until the time of discharge from recovery room, assessed up to 1 hour

Study Arms (3)

Olympus standard bite block

EXPERIMENTAL

Standard of care using standard bite block and nasal cannula

Device: Olympus standard bite block

YX Mandibular advancement bite block

EXPERIMENTAL

Mandibular advancement bite block group

Device: YX mandibular advancement bite block

Optiflow High flow nasal cannula

EXPERIMENTAL

High flow nasal cannula group

Device: Optiflow High flow nasal cannula

Interventions

Intravenous sedative upper gastrointestinal endoscopy performed under standard bite block (MB142 reusable bite block, Olympus) and nasal cannula with oxygen 5L/min

Also known as: A
Olympus standard bite block

Intravenous sedative upper gastrointestinal endoscopy performed under mandibular advancement bite block for endoscopy (Yong Xu breathing mouth piece, Yong Xu) and oxygen connected to mouth piece 5L/min

Also known as: B
YX Mandibular advancement bite block

Intravenous sedative upper gastrointestinal endoscopy performed under standard bite block (MB142 reusable bite block, Olympus) and high flow nasal cannula

Also known as: C
Optiflow High flow nasal cannula

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female patients aged 20 to 80 years with ASA physical status I to II undergoing routine outpatient upper gastrointestinal endoscopy

You may not qualify if:

  • Baseline oxygen saturation \< 90%
  • Known upper airway obstruction, difficult intubation history
  • Unstable or lost of upper and lower incisors
  • Known past oral or neck surgeries
  • Anticipate exam time \> 30 mins

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology, Taipei Veterans General Hospital

Taipei, 112, Taiwan

Location

MeSH Terms

Conditions

Airway ObstructionSleep Apnea, Obstructive

Interventions

Cesarean Section

Condition Hierarchy (Ancestors)

Respiratory InsufficiencyRespiration DisordersRespiratory Tract DiseasesSleep Apnea SyndromesApneaSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Delivery, ObstetricObstetric Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Wei-Nung Teng, MD

    Taipei Veterans General Hospital, Taiwan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 18, 2017

First Posted

May 3, 2017

Study Start

May 3, 2017

Primary Completion

June 22, 2017

Study Completion

June 22, 2017

Last Updated

July 11, 2017

Record last verified: 2017-05

Locations